News Conference News ACC 2026 Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI Yael L. Maxwell March 30, 2026
News Conference News ACC 2026 PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV Michael O'Riordan March 29, 2026
News Conference News CRT 2026 Large Variability in Use of Invasive Strategy for Type 1 NSTEMI: NCDR Michael O'Riordan March 11, 2026
News Daily News Good News for Intravascular Imaging Continues at 5 Years: RENOVATE-COMPLEX-PCI Caitlin E. Cox March 10, 2026
News Daily News HBR Common, Impactful Among All-Comer Acute MI Patients Yael L. Maxwell March 05, 2026
News Opinion Off Script Why Interventionalists Must Work Toward Global Cardiovascular Equity Tesfaye Telila, MD February 17, 2026
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2026 Caitlin E. Cox February 02, 2026
News Daily News Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI Yael L. Maxwell December 29, 2025
News Daily News Revascularization Decisions in the Elderly Require a Holistic Approach: AHA Caitlin E. Cox November 24, 2025
News Daily News Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges Caitlin E. Cox November 21, 2025
News Conference News AHA 2025 Liberal Transfusion Doesn’t Decrease MACE in Surgery Patients at High Cardiac Risk: TOP Caitlin E. Cox November 10, 2025
News Conference News AHA 2025 Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI Todd Neale November 09, 2025
News Conference News TCT 2025 INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time Michael O'Riordan October 29, 2025
News Daily News Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS Todd Neale October 03, 2025
News Daily News Risk Factors Present in Nearly All Patients Who Develop CVD Michael O'Riordan October 02, 2025
News Opinion CV Team Dispatch September 2025 Dispatch for the CV Team L.A. McKeown September 30, 2025
News Daily News CVD Still the Leading Cause of Death and Disease Globally Michael O'Riordan September 24, 2025